Advertisement
Sign up
Published: March 9, 2020
Advertisement
Top stories
Collaboration – January 16, 2025
NordForsk has decided to fund three Nordic networking activities to support knowledge development on the post-COVID condition (PCC).
Science article – January 16, 2025
A new international study led by researchers at Karolinska Institutet shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images.
Acquisition – January 15, 2025
IDRx is a Boston-based, clinical-stage biopharmaceutical company dedicated to developing precision therapeutics for the treatment of GIST.
Financing – January 15, 2025
Rappta Therapeutics has announced an exclusive global license agreement with SpringWorks Therapeutics for RPT04402, a first-in-class molecular glue of specific Protein Phosphatase 2A (PP2A) complexes.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Related posts
This site uses cookies